These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21630317)

  • 21. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
    Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
    Perales MA; Ishill N; Lomazow WA; Weinstock DM; Papadopoulos EB; Dastigir H; Chiu M; Boulad F; Castro-Malaspina HR; Heller G; Jakubowski AA; O'Reilly RJ; Small TN; Young JW; Kernan NA
    Bone Marrow Transplant; 2007 Sep; 40(5):481-6. PubMed ID: 17618322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids.
    Fossi A; Voltolini L; Filippi R; Luzzi L; Pasini FL; Marchi B; Gotti G; Rottoli P
    J Heart Lung Transplant; 2009 May; 28(5):508-10. PubMed ID: 19416782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
    Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.
    Couriel DR; Saliba R; Escalón MP; Hsu Y; Ghosh S; Ippoliti C; Hicks K; Donato M; Giralt S; Khouri IF; Hosing C; de Lima MJ; Andersson B; Neumann J; Champlin R
    Br J Haematol; 2005 Aug; 130(3):409-17. PubMed ID: 16042691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
    Greinix HT; Worel N; Knobler R
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1747-8; author reply 1749. PubMed ID: 20601039
    [No Abstract]   [Full Text] [Related]  

  • 28. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease.
    Bordigoni P; Dimicoli S; Clement L; Baumann C; Salmon A; Witz F; Feugier P
    Br J Haematol; 2006 Nov; 135(3):382-5. PubMed ID: 16984386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant].
    Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2004 Jan; 45(1):57-60. PubMed ID: 14999935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-versus-host disease following autologous transplantation.
    Baker M
    Oncol Nurs Forum; 2010 May; 37(3):269-73. PubMed ID: 20439212
    [No Abstract]   [Full Text] [Related]  

  • 32. Infliximab treatment for steroid-refractory acute graft-versus-host disease.
    Patriarca F; Sperotto A; Damiani D; Morreale G; Bonifazi F; Olivieri A; Ciceri F; Milone G; Cesaro S; Bandini G; Dini G; Corradini P; Fanin R
    Haematologica; 2004 Nov; 89(11):1352-9. PubMed ID: 15531458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibody].
    Lu J; Xu LP; Huang XJ; Chen H; Zhang YC; Ren HY; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):216-9. PubMed ID: 12812665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
    Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
    Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-CD25 monoclonal antibody with antithymocytic globulin for steroid-resistant severe acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation].
    Ye CX; Sun J; Liu QF; Qu H; Xu D; Zhang Y; Meng FY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2224-6. PubMed ID: 19114364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous methylprednisolone can cause an acute, vision-threatening rise in intraocular pressure.
    Gupta SR; Suhler EB; Rosenbaum JT
    J Clin Rheumatol; 2010 Dec; 16(8):397-8. PubMed ID: 21085011
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: an international practice survey.
    Hsu B; May R; Carrum G; Krance R; Przepiorka D
    Bone Marrow Transplant; 2001 Nov; 28(10):945-50. PubMed ID: 11753549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.
    Piton G; Larosa F; Minello A; Becker MC; Mantion G; Aubin F; Deconinck E; Hillon P; Di Martino V
    Liver Transpl; 2009 Jul; 15(7):682-5. PubMed ID: 19562700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
    Nishi T; Okazaki K; Fujii S; Uchida K; Uose S; Nakase H; Ohana M; Nishihara T; Chiba T
    Endoscopy; 2001 Nov; 33(11):985-7. PubMed ID: 11668409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
    Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
    Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.